{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:42:12Z","timestamp":1793875332716,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG077576"],"award-info":[{"award-number":["AG077576"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG057848"],"award-info":[{"award-number":["AG057848"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00259-026-07976-2","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:40:11Z","timestamp":1781332811000},"page":"6226-6237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating early vs. late static SUVR windows of [\u00b9\u2078F]MK-6240 tau PET in Alzheimer disease: a head-to-head comparison study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0320-512X","authenticated-orcid":false,"given":"Tsung-Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennette","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangdong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyuan Hugh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khalafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadek A.","family":"Nehmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silky Singh","family":"Pahlajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Hojjati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Glodzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria C.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3875-3513","authenticated-orcid":false,"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"9533","key":"7976_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H. Alzheimer\u2019s disease. Lancet. 2006;368(9533):387\u2013403. https:\/\/doi.org\/10.1016\/S0140-6736(06)69113-7.","journal-title":"Lancet"},{"issue":"4","key":"7976_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357\u201367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9.","journal-title":"Lancet Neurol"},{"issue":"11","key":"7976_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960\u20139. https:\/\/doi.org\/10.1097\/NEN.0b013e318232a379.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"7976_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","volume":"73","author":"L Wang","year":"2016","unstructured":"Wang L, Benzinger TL, Su Y, et al. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between beta-Amyloid and Tauopathy. JAMA Neurol. 2016;73(9):1070\u20137. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2078.","journal-title":"JAMA Neurol"},{"issue":"2","key":"7976_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2967\/jnumed.114.149229","volume":"56","author":"Y Li","year":"2015","unstructured":"Li Y, Tsui W, Rusinek H, et al. Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease. J Nucl Med. 2015;56(2):270\u20133. https:\/\/doi.org\/10.2967\/jnumed.114.149229.","journal-title":"J Nucl Med"},{"issue":"11","key":"7976_CR6","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1002\/alz.13158","volume":"19","author":"A Bollack","year":"2023","unstructured":"Bollack A, Pemberton HG, Collij LE, et al. Longitudinal amyloid and tau PET imaging in Alzheimer\u2019s disease: A systematic review of methodologies and factors affecting quantification. Alzheimer\u2019s Dement. 2023;19(11):5232\u201352. https:\/\/doi.org\/10.1002\/alz.13158.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"11","key":"7976_CR7","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1177\/0271678X19887781","volume":"40","author":"C Salinas","year":"2020","unstructured":"Salinas C, Lohith TG, Purohit A, et al. Test\u2013retest characteristic of [18F]MK-6240 quantitative outcomes in cognitively normal adults and subjects with Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2020;40(11):2179\u201387. https:\/\/doi.org\/10.1177\/0271678X19887781.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"7976_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","volume":"10","author":"TA Pascoal","year":"2018","unstructured":"Pascoal TA, Shin M, Kang MS, et al. In vivo quantification of neurofibrillary tangles with [18F]MK-6240. Alz Res Therapy. 2018;10(1):74. https:\/\/doi.org\/10.1186\/s13195-018-0402-y.","journal-title":"Alz Res Therapy"},{"issue":"1","key":"7976_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2967\/jnumed.118.208215","volume":"60","author":"TG Lohith","year":"2019","unstructured":"Lohith TG, Bennacef I, Vandenberghe R, et al. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles. J Nucl Med. 2019;60(1):107\u201314. https:\/\/doi.org\/10.2967\/jnumed.118.208215.","journal-title":"J Nucl Med"},{"issue":"13","key":"7976_CR10","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1007\/s00259-022-05907-5","volume":"49","author":"G Vanderlinden","year":"2022","unstructured":"Vanderlinden G, Mertens N, Michiels L, et al. Long-term test-retest of cerebral [18F]MK-6240 binding and longitudinal evaluation of extracerebral tracer uptake in healthy controls and amnestic MCI patients. Eur J Nucl Med Mol Imaging. 2022;49(13):4580\u20138. https:\/\/doi.org\/10.1007\/s00259-022-05907-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"S1","key":"7976_CR11","doi-asserted-by":"publisher","first-page":"e068139","DOI":"10.1002\/alz.068139","volume":"18","author":"C Tissot","year":"2022","unstructured":"Tissot C, Lussier FZ, Ferrari-Souza JP, et al. Impact of meningeal and age-related off-target binding on longitudinal [18F]MK6240 quantification. Alzheimer\u2019s Dement. 2022;18(S1):e068139. https:\/\/doi.org\/10.1002\/alz.068139.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"7","key":"7976_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1177\/0271678X221076023","volume":"42","author":"N Mertens","year":"2022","unstructured":"Mertens N, Michiels L, Vanderlinden G, et al. Impact of meningeal uptake and partial volume correction techniques on [18F]MK-6240 binding in aMCI patients and healthy controls. J Cereb Blood Flow Metab. 2022;42(7):1236\u201346. https:\/\/doi.org\/10.1177\/0271678X221076023.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7976_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/imag_a_00135","volume":"2","author":"A McVea","year":"2024","unstructured":"McVea A, DiFilippo A, McLachlan MJ, et al. Evaluating the effect of extra-cerebral off-target binding in [F-18]MK6240 PET scans in early-stage Alzheimer\u2019s disease. Imaging Neurosci. 2024;2:1\u201320. https:\/\/doi.org\/10.1162\/imag_a_00135.","journal-title":"Imaging Neurosci"},{"issue":"supplement 2","key":"7976_CR14","first-page":"2952","volume":"63","author":"A McVea","year":"2022","unstructured":"McVea A, DiFilippo A, McLachlan M, et al. Off-Target MK6240 Binding Decreases Detection Sensitivity in Simulated PET Scans. J Nuclear Med Soc Nuclear Med. 2022;63(supplement 2):2952\u20132952.","journal-title":"J Nuclear Med Soc Nuclear Med"},{"issue":"3","key":"7976_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2967\/jnumed.122.264434","volume":"64","author":"C Tissot","year":"2023","unstructured":"Tissot C, Servaes S, Lussier FZ, et al. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18 F]MK6240 Tau PET in Target Regions. J Nucl Med. 2023;64(3):452\u20139. https:\/\/doi.org\/10.2967\/jnumed.122.264434.","journal-title":"J Nucl Med"},{"issue":"7","key":"7976_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1177\/0271678X221076023","volume":"42","author":"N Mertens","year":"2022","unstructured":"Mertens N, Michiels L, Vanderlinden G, et al. Impact of meningeal uptake and partial volume correction techniques on [18F]MK-6240 binding in aMCI patients and healthy controls. J Cereb Blood Flow Metab. 2022;42(7):1236\u201346. https:\/\/doi.org\/10.1177\/0271678X221076023.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"7976_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2967\/jnumed.118.209650","volume":"60","author":"TJ Betthauser","year":"2019","unstructured":"Betthauser TJ, Cody KA, Zammit MD, et al. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls. J Nucl Med. 2019;60(1):93\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.209650.","journal-title":"J Nucl Med"},{"key":"7976_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40658-024-00679-3","volume":"11","author":"PN Schuck","year":"2024","unstructured":"Schuck PN, Wang XH, Tanzi EB, Xie S, Li Y, Nehmeh SA. Reproducibility of [18F]MK-6240 kinetics in brain studies with shortened dynamic PET protocol in healthy\/cognitively normal subjects. EJNMMI Phys. 2024;11:79. https:\/\/doi.org\/10.1186\/s40658-024-00679-3.","journal-title":"EJNMMI Phys"},{"issue":"Suppl 1","key":"7976_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1017\/s1041610297004870","volume":"9","author":"JC Morris","year":"1997","unstructured":"Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(Suppl 1):173\u20136. https:\/\/doi.org\/10.1017\/s1041610297004870. discussion 177-178.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"7976_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"7976_CR21","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985\u201392. https:\/\/doi.org\/10.1001\/archneur.58.12.1985.","journal-title":"Arch Neurol"},{"issue":"6","key":"7976_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/wnl.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546\u201354. https:\/\/doi.org\/10.1212\/wnl.51.6.1546.","journal-title":"Neurology"},{"issue":"4","key":"7976_CR23","doi-asserted-by":"publisher","first-page":"101164","DOI":"10.1016\/j.neurad.2023.10.009","volume":"51","author":"L Zhou","year":"2024","unstructured":"Zhou L, Butler TA, Wang XH, et al. Multimodal assessment of brain fluid clearance is associated with amyloid-beta deposition in humans. J Neuroradiol. 2024;51(4):101164. https:\/\/doi.org\/10.1016\/j.neurad.2023.10.009.","journal-title":"J Neuroradiol"},{"issue":"3","key":"7976_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2967\/jnumed.122.264371","volume":"64","author":"JP Seibyl","year":"2023","unstructured":"Seibyl JP, DuBois JM, Racine A, et al. A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18F-MK-6240 PET. J Nuclear Med Soc Nuclear Med. 2023;64(3):444\u201351. https:\/\/doi.org\/10.2967\/jnumed.122.264371.","journal-title":"J Nuclear Med Soc Nuclear Med"},{"issue":"253","key":"7976_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/01621459.1951.10500769","volume":"46","author":"FJ Massey","year":"1951","unstructured":"Massey FJ. The Kolmogorov-Smirnov Test for Goodness of Fit. J Am Stat Assoc. 1951;46(253):68\u201378. https:\/\/doi.org\/10.1080\/01621459.1951.10500769.","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"7976_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach. Biometrics. [Wiley. Int Biometric Society]. 1988;44(3):837\u201345. https:\/\/doi.org\/10.2307\/2531595.","journal-title":"Int Biometric Society]"},{"key":"7976_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1037\/h0026256","volume-title":"Psychological Bulletin","author":"J Cohen","year":"1968","unstructured":"Cohen J. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. Psychological Bulletin. Volume 70. US: American Psychological Association; 1968. pp. 213\u201320. 410.1037\/h0026256."},{"issue":"5","key":"7976_CR28","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/brain\/awab392","volume":"145","author":"JP Levy","year":"2021","unstructured":"Levy JP, Bezgin G, Savard M, et al. 18F-MK-6240 tau-PET in genetic frontotemporal dementia. Brain. 2021;145(5):1763\u201372. https:\/\/doi.org\/10.1093\/brain\/awab392.","journal-title":"Brain"},{"key":"7976_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/imag_a_00402","volume":"2","author":"C Lois","year":"2024","unstructured":"Lois C, Fu JF, Salvatore AN, et al. Test\u2013retest performance of [18F]MK-6240 tau burden and relative delivery indices in cognitively normal older subjects using PET\/MRI. Imaging Neurosci. 2024;2:1\u201320. https:\/\/doi.org\/10.1162\/imag_a_00402.","journal-title":"Imaging Neurosci"},{"issue":"supplement 2","key":"7976_CR30","first-page":"2937","volume":"63","author":"G Vanderlinden","year":"2022","unstructured":"Vanderlinden G, Mertens N, Michiels L, et al. 18F-MK-6240 SUVR long-term test-retest and assessment of meningeal tracer uptake. J Nuclear Med Soc Nuclear Med. 2022;63(supplement 2):2937\u20132937.","journal-title":"J Nuclear Med Soc Nuclear Med"},{"issue":"1","key":"7976_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0686-6","volume":"7","author":"C Aguero","year":"2019","unstructured":"Aguero C, Dhaynaut M, Normandin MD, et al. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019;7(1):1\u201315.","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"7976_CR32","first-page":"1599","volume":"57","author":"ED Hostetler","year":"2016","unstructured":"Hostetler ED, Walji AM, Zeng Z, et al. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles. JNuclMed. 2016;57(10):1599\u2013606.","journal-title":"JNuclMed"},{"issue":"6","key":"7976_CR33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00259-024-06603-2","volume":"51","author":"T G\u00e9rard","year":"2024","unstructured":"G\u00e9rard T, Colmant L, Malotaux V, et al. The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2024;51(6):1662\u201374. https:\/\/doi.org\/10.1007\/s00259-024-06603-2.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07976-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07976-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:00:35Z","timestamp":1787986835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07976-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7976"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07976-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the IRB and was conducted in compliance with HIPAA.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest and no industry support that could directly or indirectly influence this work.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GC has received consulting fees from Life Molecular Imaging and speaker honoraria from Efficient CME and PeerView. No other potential conflicts of interest relevant to this article exist.","order":5,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}]}}